Just over 20 years ago, the people of California voted to spend billions of dollars on an exciting new idea to remake medicine. Agreeing to ...

Moments after Regeneron CEO Len Schleifer scolded analysts for asking too many questions about the disappointing sales of eye ...

Marion McCourt; Executive Vice President - Commercial; Regeneron Pharmaceuticals Inc. Christopher Fenimore; Chief Financial Officer, Senior Vice President - Finance; Regeneron Pha ...

After Regeneron Chief Scientific Officer George Yancopoulos, M.D., Ph.D., spent more than 25 minutes waxing about the company’s deep pipeline Monday at the J.P. Morgan Healthcare Conference ...

Hegseth was confirmed after a 50-50 vote in the Senate, when Vice President JD Vance came to the chamber to break the tie in his role as president of the Senate.

George Yancopoulos is co-founder and chief scientific officer of Regeneron, a US biotech that is one of over 80 companies ...

Regeneron co-Chair, President and CSO George Yancopoulos discusses the company's planned weight-loss drugs with Katie Greifeld at the JPMorgan Healthcare Conference in San Francisco. South Korean ...

it has been increasingly recognized that the profound weight loss is accompanied by substantial muscle loss," Regeneron Pharmaceuticals Chief Scientific Officer George Yancopoulos said on the ...

Out of 40 students nationwide, five students from Northern California were named finalists in the prestigious talent search.

George Yancopoulos. Additionally, Regeneron (REGN) and Sanofi (SNY) updated investors on their Phase 3 program for Dupixent ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...